728 filings
Page 29 of 37
8-K
t1qjd lld607x5duxqy
25 Sep 17
Regulation FD Disclosure
12:00am
8-K
fdcdu3c8deduaud
22 Sep 17
Entry into a Material Definitive Agreement
12:00am
4
0r8 9p3srsen63
7 Aug 17
PROTEOSTASIS THERAPEUTICS / M JAMES BARRETT ownership change
12:00am
4
bg8h0y 53u0ca
7 Aug 17
PROTEOSTASIS THERAPEUTICS / FRANKLIN M BERGER ownership change
12:00am
4
mhfxl
7 Aug 17
PROTEOSTASIS THERAPEUTICS / Jeffery W. Kelly ownership change
12:00am
8-K
pvnil91
4 Aug 17
Submission of Matters to a Vote of Security Holders
12:00am
4
5nd99u
3 Aug 17
PROTEOSTASIS THERAPEUTICS / Helen M Boudreau ownership change
12:00am
8-K
3soyr8w20sezcttq
31 Jul 17
Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer
12:00am
DEFA14A
96xuqpt7 svg
31 Jul 17
Additional proxy soliciting materials
12:00am
8-K
hb0div7v2wb1n6j4
31 Jul 17
Regulation FD Disclosure
12:00am
EFFECT
nennm bb6u
3 Jul 17
Notice of effectiveness
12:00am
8-K
hc6apmtwyyjyo76g09ap
29 Jun 17
Proteostasis Therapeutics Reports Preliminary Data from Phase 1 Study ofPTI-428 in Patients with Cystic Fibrosis
12:00am
CORRESP
3tadwx zeer785tqi
29 Jun 17
Correspondence with SEC
12:00am
S-3/A
to2rcua83 vuaolwd3
22 Jun 17
Shelf registration (amended)
12:00am
DEFA14A
vsheb 7b9hm
8 Jun 17
Additional proxy soliciting materials
12:00am
DEFR14A
2yce2iboggmj3o qsjxx
8 Jun 17
Revised proxy
12:00am
8-K
t0d2mkvi
8 Jun 17
Regulation FD Disclosure
12:00am
8-K
1et80hq ubev8
7 Jun 17
Proteostasis Therapeutics Announces Clinical and Regulatory Progress Across Pipeline Programs
12:00am
S-3
6jlpdd u1ru
7 Jun 17
Shelf registration
12:00am